Rupee rises 14 paise to close at 86.59 against U.S. dollar
The Hindu
Rupee strengthens against the dollar on global cues, FII inflows, and domestic equity market performance.
Aurobindo Pharma's subsidiary receives Health Canada NOC for Dyrupeg, confirming its pegylated filgrastim biosimilar's safety and efficacy.
SEBI exempts small brokers from the technical glitch framework, impacting 60% of stock brokers in India.
Vodafone Idea confirms ₹124 crore annual AGR dues until 2031, following government relief approval for the struggling telecom firm.
With digital technologies dominating the financial landscape and redefining the operations of regulated entities, regulation and supervision by the regulator must remain risk-based, proportionate, and technology-neutral said Reserve Bank of India (RBI) Governor Sanjay Malhotra.
Ashok Leyland Ltd. on Friday inaugurated its integrated commercial vehicle plant focused on green mobility at Lucknow in Uttar Pradesh.
Bharat Coking Coal IPO saw 8.1 times subscription on Day 1, driven by strong retail and institutional investor demand.
India's forex reserves fell by $9.80 billion to $686.80 billion, following a previous increase of $3.29 billion.
Indian stock markets decline for the fifth consecutive day amid concerns over U.S. tariffs and foreign capital flight.
Rupee falls 26 paise to 90.16 against the U.S. dollar, pressured by a strong dollar and weak equity markets.
As devices from toys to cars get smarter at the Consumer Electronics Show, gadget makers are grappling with a shortage of memory and storage needed for them to work.
Benchmark indices Sensex and Nifty decline amid foreign fund outflows and renewed U.S. tariff hike concerns, impacting investor sentiment.
The rupee declines 7 paise to 89.97 against the U.S. dollar amid foreign fund outflows and rising crude prices.
India’s information technology firms are expected to report another muted quarter